{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:34:06Z","timestamp":1789842846753,"version":"4.0.1"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,19]]},"DOI":"10.7759\/cureus.79309","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T18:15:26Z","timestamp":1739988926000},"source":"Crossref","is-referenced-by-count":1,"title":["Euglycemic Diabetic Ketoacidosis (DKA) With Sodium-Glucose Transport Protein 2 (SGLT-2) Inhibitors"],"prefix":"10.7759","author":[{"given":"Ahmed","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiman","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossam","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4147","article-title":"Diabetic ketoacidosis with SGLT2 inhibitors","volume":"371","author":"Musso G","year":"2020","unstructured":"Musso G, Saba F, Cassader M, Gambino R. Diabetic ketoacidosis with SGLT2 inhibitors. BMJ. 2020, 371:4147. 10.1136\/bmj.m4147","journal-title":"BMJ"},{"key":"ref2","article-title":"Euglycemic diabetic ketoacidosis","author":"Plewa MC","year":"2025","unstructured":"Plewa MC, Bryant M, King-Thiele R. Euglycemic diabetic ketoacidosis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0843","article-title":"Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition","volume":"38","author":"Peters AL","year":"2015","unstructured":"Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015, 38:1687-93. 10.2337\/dc15-0843","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2014.909407","article-title":"Empagliflozin, a sodium glucose co-transporter 2 inhibitor, in the treatment of type 1 diabetes","volume":"23","author":"Lamos EM","year":"2014","unstructured":"Lamos EM, Younk LM, Davis SN. Empagliflozin, a sodium glucose co-transporter 2 inhibitor, in the treatment of type 1 diabetes. Expert Opin Investig Drugs. 2014, 23:875-82. 10.1517\/13543784.2014.909407","journal-title":"Expert Opin Investig Drugs"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.828649","article-title":"New diabetic medication sodium-glucose cotransporter-2 inhibitors can induce euglycemic ketoacidosis and mimic surgical diseases: a case report and review of literature","volume":"9","author":"Kietaibl AT","year":"2022","unstructured":"Kietaibl AT, Fasching P, Glaser K, Petter-Puchner AH. New diabetic medication sodium-glucose cotransporter-2 inhibitors can induce euglycemic ketoacidosis and mimic surgical diseases: a case report and review of literature. Front Surg. 2022, 9:828649. 10.3389\/fsurg.2022.828649","journal-title":"Front Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/342432-euglycemic-diabetic-ketoacidosis-dka-with-sodium-glucose-transport-protein-2-sglt-2-inhibitors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T18:15:27Z","timestamp":1739988927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/342432-euglycemic-diabetic-ketoacidosis-dka-with-sodium-glucose-transport-protein-2-sglt-2-inhibitors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":5,"URL":"https:\/\/doi.org\/10.7759\/cureus.79309","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,19]]}}}